Test Price
2,800 AED✅ Home Collection Available
RXYLT1 Gene Muscular Dystrophy‑Dystroglycanopathy (Congenital with Brain and Eye Anomalies), Type A10 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين RXYLT1 لضمور العضلات-خلل الجليكوكانوثي (خلقي مع تشوهات دماغية وعينية) من النوع A10 في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
الملخص التنفيذي للثقة
- ضمان الدقة: حساسية تشخيصية بنسبة 99.9% من خلال معالجة معتمدة بموجب ISO.
- النقل المتميز: خدمة جمع العينات المنزلية عالية الجودة تحت إشراف سلسلة تبريد معتمدة ISO وخدمة الفصد المنزلي VIP.
- الإرشاد السريري: استشارة سريرية هاتفية بعد الفحص لتفسير النتائج.
- التأمين: التحقق من الفوترة المباشرة عبر واتساب +971 54 548 8731.
UAE Regulatory & Legal Compliance
- ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139)
- Fully compliant with Federal Decree-Law No. 41 of 2024 (Article 87) – Medical Liability
- Adheres to CDS Law 2026 for genetic testing on minors
- Strictly follows UAE PDPL (Personal Data Protection Law) for genetic privacy
Overview
The RXYLT1 gene test detects pathogenic variants responsible for muscular dystrophy-dystroglycanopathy type A10, a devastating congenital disorder impairing muscle, brain, and ocular development. This next‑generation sequencing (NGS) analysis delivers a definitive molecular diagnosis for patients presenting with a Walker‑Warburg‑like phenotype, enabling precise clinical management and genetic counselling.
يكشف تحليل جين RXYLT1 عن الطفرات المسببة لحثل العضلات-خلل الجليكوكانوثي من النوع A10، وهو اضطراب خلقي وخيم يؤثر على العضلات والدماغ والعينين. يوفر تحليل التسلسل الجيني من الجيل التالي (NGS) تشخيصًا نهائيًا للمرضى المشتبه بإصابتهم بمتلازمة شبيهة بووكر-واربرغ، مما يوجه التدبير السريري والاستشارة الوراثية.
Our Test vs. Closest Alternative
| Feature | Our RXYLT1 NGS Test | Traditional Sanger Sequencing |
|---|---|---|
| Genetic Coverage | Whole gene + flanking regions, deep sequencing | Single gene, hotspot regions only |
| Analytical Sensitivity | >99.9% | ~95‑98% |
| Turnaround Time | 3–4 weeks | 6–8 weeks |
| Methodology | Next‑Generation Sequencing (NGS) with robust bioinformatics | Sanger sequencing (time‑consuming per amplicon) |
| Clinical Reporting | DHA‑aligned report with ICD‑10, LOINC, & genetic counselling note | Basic variant call without integrated interpretation |
Physician Insight & Safety Protocol
“Understanding your child’s complex neurological and muscular symptoms can be overwhelming. As a senior medical geneticist, I advise that this test is a crucial step in confirming the underlying genetic cause, but it must be interpreted alongside a comprehensive clinical evaluation. Every result should be discussed with a specialized neurologist and genetic counselor to guide your family's journey with informed care and support.”
— Dr. Prabhakar Reddy, DHA License: 61713011
Medication Warning
Do not discontinue prescribed medication without consulting your doctor.
Safety Exclusion & Emergency Red Flags
- Exclusion Criteria: This test is not intended for asymptomatic individuals without clinical suspicion of MDDGA10. Patients with known bleeding disorders or those on anticoagulant/antiplatelet therapy must inform the phlebotomist prior to sample collection.
- Post‑Collection Red Flags: If you or the patient experience persistent oozing, swelling, fever, or severe pain at the draw site, seek medical attention immediately.
- Neurological Emergency: Should new‑onset seizures, acute vision loss, sudden muscle weakness, or respiratory difficulty occur, go to the nearest Emergency Department without delay.
Frequently Asked Questions & Clinical Guidance
Q1: What is the RXYLT1 gene and why is this test performed?
The RXYLT1 gene encodes an enzyme essential for proper muscle and brain development; mutations cause severe congenital muscular dystrophy.
This NGS test identifies pathogenic variants in the RXYLT1 gene that lead to muscular dystrophy‑dystroglycanopathy type A10 (MDDGA10), a disorder affecting the muscles, brain, and eyes. It is ordered when a newborn or child presents with hypotonia, brain malformations (e.g., cobblestone lissencephaly), and ocular defects suggestive of Walker‑Warburg syndrome. A definitive result informs prognosis, recurrence risk, and family planning.
س1: ما هو جين RXYLT1 ولماذا يُجرى هذا الاختبار؟
يشفر جين RXYLT1 إنزيمًا ضروريًا لنمو العضلات والدماغ الطبيعي؛ وتؤدي الطفرات فيه إلى حثل عضلي خلقي وخيم.
Q2: Who should consider this genetic test?
Any infant or child presenting with hypotonia, brain malformations, and eye anomalies should undergo RXYLT1 sequencing immediately.
This is indicated for patients with a clinical picture of congenital muscular dystrophy accompanied by structural brain abnormalities and ocular involvement. Referring specialists—neurologists, paediatricians, and ophthalmologists—may recommend it as a first‑tier molecular investigation. It is also valuable for carrier testing in family members and for prenatal genetic counselling when a familial mutation is known.
س2: من الذي يجب أن يفكر في إجراء هذا الاختبار الجيني؟
أي رضيع أو طفل يعاني من نقص التوتر العضلي وتشوهات دماغية وعينية ينبغي أن يخضع لتسلسل جين RXYLT1 فورًا.
Q3: How is the sample collected and what is the turnaround time?
A simple blood draw or buccal swab is sent for NGS analysis; results are returned in three to four weeks.
Our DHA‑licensed phlebotomy team collects a blood sample (or an FTA card/ buccal swab) via our premium home collection service, operating daily 8 AM – 11 PM. The specimen is transported in ISO‑certified cold‑chain conditions to the sequencing laboratory. You will receive a comprehensive clinical report, reviewed by a medical geneticist, within 3 to 4 weeks. Direct billing verification and insurance coordination are available through WhatsApp at +971 54 548 8731.
س3: كيف تُجمع العينة وكم تستغرق النتيجة؟
تُسحب عينة دم بسيطة أو مسحة فموية وتُرسل لتحليل التسلسل الجيني NGS؛ وتصدر النتائج في غضون ثلاثة إلى أربعة أسابيع.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians